{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:08:40Z","timestamp":1768000120566,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.urolonc.2020.02.025","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T01:23:00Z","timestamp":1585099380000},"page":"793.e19-793.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-3521","authenticated-orcid":false,"given":"Francesca","family":"Sanguedolce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1152-3005","authenticated-orcid":false,"given":"Ugo Giovanni","family":"Falagario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Castellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Di Nauta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Silecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore M.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick-Julien","family":"Treacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh K.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.02.025_bib0001","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0003","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0004","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0005","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0006","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0007","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.urolonc.2018.01.007","article-title":"Association among metabolic syndrome, inflammation, and survival in prostate cancer","volume":"36","author":"Conteduca","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3140372","article-title":"From Inflammation to prostate cancer: the role of inflammasomes","volume":"2016","author":"Karan","year":"2016","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0009","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1158\/0008-5472.CAN-14-0369","article-title":"Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer","volume":"74","author":"Stallone","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0010","series-title":"EAU - ESTRO - ESUR - SIOG guidelines on prostate cancer 2018. European Association of Urology Guidelines 2018 edition","author":"Mottet","year":"2018"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0011","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","article-title":"Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value","volume":"157","author":"Irani","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0012","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.eururo.2007.06.038","article-title":"Inflammation and chronic prostatic diseases: evidence for a link?","volume":"52","author":"Sciarra","year":"2007","journal-title":"Eur Urol."},{"key":"10.1016\/j.urolonc.2020.02.025_bib0013","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.urolonc.2018.01.012","article-title":"Metabolic syndrome is not associated with greater evidences of proliferative inflammatory atrophy and inflammation in patients with suspected prostate cancer","volume":"36","author":"Russo","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0014","first-page":"178","article-title":"Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer","volume":"2018","author":"Falagario","year":"2018","journal-title":"J Gerontol Geriatr"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0015","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.juro.2017.11.120","article-title":"Inflammation on prostate needle biopsy is associated with lower prostate cancer risk: a meta-analysis","volume":"199","author":"Vasavada","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0016","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00345-018-2409-1","article-title":"The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study","volume":"37","author":"Gravas","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0017","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.urolonc.2010.09.004","article-title":"Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel","volume":"31","author":"Cormio","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0018","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1464-410X.2011.10622.x","article-title":"Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy","volume":"109","author":"Cormio","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0019","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00345-012-0989-8","article-title":"Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?","volume":"32","author":"Cormio","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0021","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0022","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1016\/j.clgc.2017.04.024","article-title":"Grade group underestimation in prostate biopsy: predictive factors and outcomes in candidates for active surveillance","volume":"15","author":"Audenet","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0023","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","article-title":"Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades","volume":"61","author":"Epstein","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0024","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/bju.14391","article-title":"How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator","volume":"122","author":"Gandaglia","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.6004\/jnccn.2018.0036","article-title":"NCCN guidelines updates: prostate cancer and prostate cancer early detection","volume":"16","author":"Carroll","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0026","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.2017.74.2940","article-title":"Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer","volume":"36","author":"Spratt","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0027","article-title":"MP18-15 A model based on four Kallikrein markers in blood improves the predictive accuracy of adverse pathology and biochemical recurrence after radical prostatectomy","volume":"201","author":"Haese","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0028","article-title":"Avoiding unnecessary magnetic resonance imaging (MRI) and biopsies: negative and positive predictive value of MRI according to prostate-specific antigen density, 4Kscore and risk calculators","author":"Falagario","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0029","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.eururo.2016.08.015","article-title":"The incremental role of magnetic resonance imaging for prostate cancer staging before radical prostatectomy","volume":"71","author":"Morlacco","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0030","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.juro.2018.06.041","article-title":"Multiparametric magnetic resonance imaging features identify aggressive prostate cancer at the phenotypic and transcriptomic level","volume":"200","author":"Beksac","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0031","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/JU.0000000000000134","article-title":"Defining prostate cancer at favorable intermediate risk: the potential utility of magnetic resonance imaging and genomic tests","volume":"202","author":"Falagario","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0032","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.juro.2013.05.021","article-title":"The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer","volume":"190","author":"Somford","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0033","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jmri.25948","article-title":"All over the map: an interobserver agreement study of tumor location based on the PI-RADSv2 sector map","volume":"48","author":"Greer","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0034","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.urolonc.2017.12.013","article-title":"Prostate magnetic resonance imaging: the truth lies in the eye of the beholder","volume":"36","author":"Riney","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0035","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000000774","article-title":"Staging Accuracy of Multiparametric MRI in Caucasian and African American patients undergoing radical prostatectomy","author":"Falagario","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7150\/jca.37235","article-title":"Correlation between prostatitis, benign prostatic hyperplasia and prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer."},{"key":"10.1016\/j.urolonc.2020.02.025_bib0037","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.juro.2008.01.034","article-title":"Evaluation of prostatitis in autopsied prostates\u2013is chronic inflammation more associated with benign prostatic hyperplasia or cancer?","volume":"179","author":"Delongchamps","year":"2008","journal-title":"J Urol."},{"key":"10.1016\/j.urolonc.2020.02.025_bib0038","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1742-1241.2006.00905.x","article-title":"Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy","volume":"61","author":"Karakiewicz","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0039","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bju.12153","article-title":"Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial","volume":"112","author":"Yli-Hemminki","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cncr.28349","article-title":"Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study","volume":"120","author":"Moreira","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0041","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fonc.2018.00438","article-title":"Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy","volume":"8","author":"Cormio","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0042","doi-asserted-by":"crossref","first-page":"e2551","DOI":"10.1097\/MD.0000000000002551","article-title":"Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy","volume":"95","author":"Cormio","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0043","first-page":"486","article-title":"Presence and severity of lower urinary tract symptoms are inversely correlated with the risk of prostate cancer on prostate biopsy","volume":"69","author":"Cicione","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0044","first-page":"2175","article-title":"Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer","volume":"35","author":"Cormio","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2020.02.025_bib0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0090-4295(99)00152-1","article-title":"High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group","volume":"54","author":"Irani","year":"1999","journal-title":"Urology."},{"key":"10.1016\/j.urolonc.2020.02.025_bib0046","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-5347(01)63093-3","article-title":"Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer","volume":"160","author":"Troy","year":"1998","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:58Z","timestamp":1761041998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920300661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1078143920300661"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.025","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}